In the fight against cancer, the pursuit of personalized medicine offers hope like never before. Our founder, Dr. Ioannis Papasotiriou, is a distinguished and renowned expert in personalized cancer care.
Traditional cancer diagnosis techniques often involve tissue biopsies, imaging tests, and clinical assessments. While these methods have been the backbone of cancer detection, they have limitations and challenges.
Knowing how to identify visible signs of breast cancer can mean the difference between an early diagnosis and a delayed or poor prognosis.
Breast cancer is a formidable adversary, affecting millions of lives worldwide. The American Cancer Society estimates that about 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States in 2023.
Imagine an army of rogue cells moving through your bloodstream stealthily, trying to establish new territories in distant organs. This may sound like a literary interpretation, but these stealthy intruders, known as Circulating Tumor Cells (CTCs), indicate the hidden presence of cancer.
